Laurie J. Hall Trustee’s Aerie Pharmaceuticals AERI Stock Holding History

Laurie J. Hall Trustee’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-485	Closed	-$7K	–	324
2022 Q3	$7K	Sell	485 -225	-32%	-$2.62K	﹤0.01%	271
2022 Q2	$5K	Hold	710	–	–	﹤0.01%	290
2022 Q1	$6K	Buy	710 +300	+73%	+$2.31K	﹤0.01%	297
2021 Q4	$3K	Hold	410	–	–	﹤0.01%	313
2021 Q3	$5K	Sell	410 -260	-39%	-$3.8K	﹤0.01%	301
2021 Q2	$11K	Hold	670	–	–	﹤0.01%	284
2021 Q1	$12K	Hold	670	–	–	﹤0.01%	285
2020 Q4	$9K	Buy	670 +270	+68%	+$3.26K	﹤0.01%	285
2020 Q3	$5K	Buy	+400	New	+$4.87K	﹤0.01%	296
2019 Q4	$5K	Buy	200 +40	+25%	+$828	﹤0.01%	301
2019 Q3	$3K	Buy	+160	New	+$3.67K	﹤0.01%	310

Laurie J. Hall Trustee's AERI Position: Q4 2022 in Review

Laurie J. Hall Trustee sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 485 shares — an estimated $7K sold.

Laurie J. Hall Trustee first reported a position in AERI in Q3 2019 and held it in 11 quarters. The position peaked at $12K in Q1 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Laurie J. Hall Trustee reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Laurie J. Hall Trustee sold 485 Aerie Pharmaceuticals shares in Q4 2022, an estimated $7K.
Laurie J. Hall Trustee first reported a position in Aerie Pharmaceuticals in Q3 2019 and held it in 11 quarters.
Laurie J. Hall Trustee's Aerie Pharmaceuticals position peaked at $12K in Q1 2021.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Laurie J. Hall Trustee's 13F filing for Q4 2022, filed 11 Jan 2023.